2014
DOI: 10.1007/s10529-014-1657-4
|View full text |Cite
|
Sign up to set email alerts
|

Production and purification of recombinant hypocholesterolemic peptides

Abstract: Elevated concentrations of cholesterol in plasma are associated with increased risk for heart diseases in humans. Bioactive peptides can be considered as an option to prevent or treat this condition. Currently, there are wide sources of bioactive peptides with hypocholesterolemic activities; however, most researches are focused in bioactive peptides derived from soybean and milk protein. Although there are several preparation methods for these peptides, it is a novel process to prepare bioactive peptides by ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
0
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 82 publications
1
6
0
2
Order By: Relevance
“…The peptides are thought to act by disrupting the micellar solubility and absorption of dietary cholesterol, altering enterohepatic bile acid circulation and elevating cholesterol catabolism, and regulating lipogenic proteins and genes. Moreover, high yields of food-derived hypolipidemic peptides (e.g., IIAEK, VPDPR, DPR) have been successfully expressed in Escherichia coli , and the resulting peptides demonstrated lipid-lowering activities when fed to rats [19]. This would encourage industry scale production of the peptides for future commercial applications.…”
Section: Dietary Peptides and Hyperlipidemiamentioning
confidence: 99%
“…The peptides are thought to act by disrupting the micellar solubility and absorption of dietary cholesterol, altering enterohepatic bile acid circulation and elevating cholesterol catabolism, and regulating lipogenic proteins and genes. Moreover, high yields of food-derived hypolipidemic peptides (e.g., IIAEK, VPDPR, DPR) have been successfully expressed in Escherichia coli , and the resulting peptides demonstrated lipid-lowering activities when fed to rats [19]. This would encourage industry scale production of the peptides for future commercial applications.…”
Section: Dietary Peptides and Hyperlipidemiamentioning
confidence: 99%
“…Thus, peptides being the inhibitors of the above-mentioned enzymes may be considered anti-MetS agents [5]. Additionally, peptides also reduce cholesterol level, antioxidative stress [6], act as anti-obesity [7], and anti-inflammatory agents [8].…”
Section: Antidiabetic Agentsmentioning
confidence: 99%
“…Bioactive peptides can be regarded as an alternative for prophylaxis or treatment of these disorders. Peptides identified as hypocholestero lemic include lactostatin (IIAEK), enterostatin (VPDPR), peptides DPR, LPYP and LPLPR [40]. It is assumed that peptides of this type have different mechanisms of action and can increase excretion of bile acids with feces, bind with phospholipids and exert the activity of the cholesterol level reduction in human serum.…”
Section: Hypocholesterolemic Peptidementioning
confidence: 99%